WAL801CL

epinastine hydrochloride · Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for WAL801CL, covering 2014-07-14 to 2014-07-14. Get the full timeline:

Most recent: Clinical Trial Update: WAL801CL (Epinastine Hydrochloride) Dry Syrup in Paediatric Perennial Allergic Rhinitis [Phase 3]